Multipurpose Vaccine Shows New Promise in the Presence of Pre-Existing Immunity
August 27, 2024
August 27, 2024
PASADENA, California, Aug. 27 -- The California Institute of Technology issued the following news:
As researchers estimate that nearly all Americans have been exposed to SARS-CoV-2, the virus that causes COVID-19, whether through infection or vaccination, we are no longer "immunologically naive"--in other words, our immune systems are familiar with certain variants of SARS-CoV-2. This familiarity can pose a problem for vaccine development.
In immunology, the p . . .
As researchers estimate that nearly all Americans have been exposed to SARS-CoV-2, the virus that causes COVID-19, whether through infection or vaccination, we are no longer "immunologically naive"--in other words, our immune systems are familiar with certain variants of SARS-CoV-2. This familiarity can pose a problem for vaccine development.
In immunology, the p . . .